These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27769735)

  • 1. Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.
    Shrestha R; Karki P; Huedo-Medina TB; Copenhaver M
    J Assoc Nurses AIDS Care; 2017; 28(1):85-94. PubMed ID: 27769735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
    Shrestha R; Copenhaver MM
    Addict Behav; 2018 Oct; 85():88-93. PubMed ID: 29879611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.
    Shrestha R; Karki P; Huedo-Medina TB; Copenhaver M
    J Assoc Nurses AIDS Care; 2017; 28(4):612-621. PubMed ID: 28478870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients.
    Shrestha R; Altice FL; Copenhaver MM
    J Acquir Immune Defic Syndr; 2019 Feb; 80(2):166-173. PubMed ID: 30383588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
    Uhlmann S; Milloy MJ; Kerr T; Zhang R; Guillemi S; Marsh D; Hogg RS; Montaner JS; Wood E
    Addiction; 2010 May; 105(5):907-13. PubMed ID: 20331553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
    Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
    Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia.
    Chan PY; Joseph MA; Des Jarlais DC; Uusküla A
    Int J STD AIDS; 2018 Jan; 29(1):13-22. PubMed ID: 28618981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.
    Reddon H; Milloy MJ; Simo A; Montaner J; Wood E; Kerr T
    AIDS Behav; 2014 Apr; 18(4):740-6. PubMed ID: 23918244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.
    Palepu A; Milloy MJ; Kerr T; Zhang R; Wood E
    J Urban Health; 2011 Jun; 88(3):545-55. PubMed ID: 21409604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interest in use of mHealth technology in HIV prevention and associated factors among high-risk drug users enrolled in methadone maintenance program.
    Shrestha R; Karki P; Copenhaver M
    AIDS Care; 2017 Sep; 29(9):1144-1148. PubMed ID: 28478706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antiretroviral therapy in HIV-positive, male intravenous drug users in Pakistan.
    Ali B; Nisar N; Nawab F
    East Mediterr Health J; 2018 Jun; 24(3):237-242. PubMed ID: 29908018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.
    Huedo-Medina TB; Shrestha R; Copenhaver M
    AIDS Behav; 2016 Aug; 20(8):1646-57. PubMed ID: 27052845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.
    Stein MD; Urdaneta ME; Clarke J; Maksad J; Sobota M; Hanna L; Markson LE
    J Addict Dis; 2000; 19(1):85-94. PubMed ID: 10772605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.
    Gonzalez A; Mimiaga MJ; Israel J; Andres Bedoya C; Safren SA
    AIDS Behav; 2013 Jan; 17(1):168-73. PubMed ID: 23008124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania.
    Cooke A; Saleem H; Mushi D; Mbwambo J; Hassan S; Lambdin BH
    Addict Sci Clin Pract; 2017 Oct; 12(1):23. PubMed ID: 29041950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. If You Build It, Will They Use It? Preferences for Antiretroviral Therapy (ART) Adherence Monitoring Among People Who Inject Drugs (PWID) in Kazakhstan.
    Davis A; Sarsembayeva L; Gulyaev V; Primbetova S; Terlikbayeva A; Mergenova G; Remien RH
    AIDS Behav; 2019 Dec; 23(12):3294-3305. PubMed ID: 30741397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
    Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
    HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.